- Home
- SYBX vs YYAI Comparison
SYBX vs YYAI Comparison
Compare SYBX & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- YYAI
- Stock Information
- Founded
- SYBX N/A
- YYAI 2015
- Country
- SYBX United States
- YYAI Hong Kong
- Employees
- SYBX N/A
- YYAI N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- YYAI
- Sector
- SYBX Health Care
- YYAI
- Exchange
- SYBX Nasdaq
- YYAI NYSE
- Market Cap
- SYBX 13.6M
- YYAI 12.9M
- IPO Year
- SYBX N/A
- YYAI N/A
- Fundamental
- Price
- SYBX $1.21
- YYAI $0.87
- Analyst Decision
- SYBX
- YYAI
- Analyst Count
- SYBX 0
- YYAI 0
- Target Price
- SYBX N/A
- YYAI N/A
- AVG Volume (30 Days)
- SYBX 12.2K
- YYAI 135.1K
- Earning Date
- SYBX 06-17-2025
- YYAI 08-05-2025
- Dividend Yield
- SYBX N/A
- YYAI N/A
- EPS Growth
- SYBX N/A
- YYAI N/A
- EPS
- SYBX 0.21
- YYAI N/A
- Revenue
- SYBX N/A
- YYAI N/A
- Revenue This Year
- SYBX N/A
- YYAI N/A
- Revenue Next Year
- SYBX N/A
- YYAI N/A
- P/E Ratio
- SYBX $5.82
- YYAI N/A
- Revenue Growth
- SYBX N/A
- YYAI N/A
- 52 Week Low
- SYBX $0.90
- YYAI $0.35
- 52 Week High
- SYBX $1.88
- YYAI $18.96
- Technical
- Relative Strength Index (RSI)
- SYBX 58.34
- YYAI 53.38
- Support Level
- SYBX $1.00
- YYAI $0.77
- Resistance Level
- SYBX $1.27
- YYAI $0.86
- Average True Range (ATR)
- SYBX 0.04
- YYAI 0.06
- MACD
- SYBX 0.01
- YYAI -0.00
- Stochastic Oscillator
- SYBX 69.05
- YYAI 59.30
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.